Presentation is loading. Please wait.

Presentation is loading. Please wait.

Copyright © 2005 American Medical Association. All rights reserved.

Similar presentations


Presentation on theme: "Copyright © 2005 American Medical Association. All rights reserved."— Presentation transcript:

1 Copyright © 2005 American Medical Association. All rights reserved.
From: Opposite Bone Remodeling Effects of Teriparatide and Alendronate in Increasing Bone Mass Arch Intern Med. 2005;165(15): doi: /archinte Figure Legend: Percentage change (mean ± SE) from baseline in serum procollagen type I N-terminal propeptide (PINP) and urinary N-telopeptide corrected for creatinine (NTx) in the alendronate and teriparatide treatment groups. Asterisk indicates P<.05; dagger, P<.001. Date of download: 10/13/2017 Copyright © 2005 American Medical Association. All rights reserved.

2 Copyright © 2005 American Medical Association. All rights reserved.
From: Opposite Bone Remodeling Effects of Teriparatide and Alendronate in Increasing Bone Mass Arch Intern Med. 2005;165(15): doi: /archinte Figure Legend: Percentage change (mean ± SE) from baseline in lumbar spine bone mineral density. The numbers of patients with postbaseline dual-energy x-ray absorptiometry (DXA) and quantitative computed tomography (QCT) measurements were 91 and 23, respectively, in the alendronate group and 96 and 26, respectively, in the teriparatide group. Asterisk indicates P<.05; dagger, P<.01; and double dagger, P<.001 (alendronate vs teriparatide for all). Date of download: 10/13/2017 Copyright © 2005 American Medical Association. All rights reserved.

3 Copyright © 2005 American Medical Association. All rights reserved.
From: Opposite Bone Remodeling Effects of Teriparatide and Alendronate in Increasing Bone Mass Arch Intern Med. 2005;165(15): doi: /archinte Figure Legend: Percentage change (mean ± SE) from baseline to month 18 in femoral neck bone mineral density. The numbers of patients with month-18 dual-energy x-ray absorptiometry (DXA) and quantitative computed tomography (QCT) measurements were 72 and 18, respectively, in the alendronate group and 69 and 20, respectively, in the teriparatide group. Asterisk indicates P = .05 (alendronate vs teriparatide). Date of download: 10/13/2017 Copyright © 2005 American Medical Association. All rights reserved.

4 Copyright © 2005 American Medical Association. All rights reserved.
From: Opposite Bone Remodeling Effects of Teriparatide and Alendronate in Increasing Bone Mass Arch Intern Med. 2005;165(15): doi: /archinte Figure Legend: Correlation between the serum procollagen type I N-terminal propeptide (PINP) area under the curve (AUC) from the first 6 months of treatment and the dual-energy x-ray absorptiometry (DXA) lumbar spine bone mineral density (BMD) at the study end point. Date of download: 10/13/2017 Copyright © 2005 American Medical Association. All rights reserved.


Download ppt "Copyright © 2005 American Medical Association. All rights reserved."

Similar presentations


Ads by Google